Chargement en cours...
Pharmacological Treatment of Alzheimer’s Disease: Is it Progressing Adequately?
INTRODUCTION: Between 1993 and 2000 four acetylcholinesterase inhibitors were marketed as a symptomatic treatment for Alzheimer’s disease (AD), as well as memantine in 2003. Current research is focused on finding drugs that favorably modify the course of the disease. However, their entrance into the...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bentham Open
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2684708/ https://ncbi.nlm.nih.gov/pubmed/19461897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874205X00903010027 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|